Cargando…

Strahlenanwendung in der Diagnostik von COVID-19: Stellungnahme der Strahlenschutzkommission

ISSUE: Since the start of the global pandemic, a number of publications have suggested using ionising radiation to diagnose a COVID-19 infection. Some proposals call for the use of computed tomography (CT) to screen for presymptomatic SARS-CoV-2-infections. INTENT OF THE CONSULTATION: With these pro...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422056/
https://www.ncbi.nlm.nih.gov/pubmed/34491367
http://dx.doi.org/10.1007/s00117-021-00898-0
_version_ 1783749208951488512
collection PubMed
description ISSUE: Since the start of the global pandemic, a number of publications have suggested using ionising radiation to diagnose a COVID-19 infection. Some proposals call for the use of computed tomography (CT) to screen for presymptomatic SARS-CoV-2-infections. INTENT OF THE CONSULTATION: With these proposals in mind, the German Commission on Radiological Protection (SSK) agreed during its 307th meeting on 2 and 3 July 2020 to establish a working group aimed at evaluating the use of ionising radiation in connection with a COVID-19 infection. The working group focussed on radiological protection aspects with a view to using computed tomography to diagnose COVID-19. The group started its work on 5 October 2020. Although not commissioned by the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU), representatives of the BMU and the Federal Office for Radiation Protection (BfS) were involved in the consultations. STATEMENT: The SSK issues the following statement: 1. The use of CT in asymptomatic persons to diagnose COVID-19 outside of approved studies is not evidentially justified. 2. Pursuant to Section 83 (3) of the German Radiation Protection Act, a CT scan for the diagnosis or follow-up of a COVID-19 pneumonia requires the prior justifying indication from a doctor with the requisite specialist knowledge in radiation protection. To this end, specialist medical associations provide recommendations based on up-to-date findings.
format Online
Article
Text
id pubmed-8422056
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-84220562021-09-07 Strahlenanwendung in der Diagnostik von COVID-19: Stellungnahme der Strahlenschutzkommission Radiologe Leitthema ISSUE: Since the start of the global pandemic, a number of publications have suggested using ionising radiation to diagnose a COVID-19 infection. Some proposals call for the use of computed tomography (CT) to screen for presymptomatic SARS-CoV-2-infections. INTENT OF THE CONSULTATION: With these proposals in mind, the German Commission on Radiological Protection (SSK) agreed during its 307th meeting on 2 and 3 July 2020 to establish a working group aimed at evaluating the use of ionising radiation in connection with a COVID-19 infection. The working group focussed on radiological protection aspects with a view to using computed tomography to diagnose COVID-19. The group started its work on 5 October 2020. Although not commissioned by the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU), representatives of the BMU and the Federal Office for Radiation Protection (BfS) were involved in the consultations. STATEMENT: The SSK issues the following statement: 1. The use of CT in asymptomatic persons to diagnose COVID-19 outside of approved studies is not evidentially justified. 2. Pursuant to Section 83 (3) of the German Radiation Protection Act, a CT scan for the diagnosis or follow-up of a COVID-19 pneumonia requires the prior justifying indication from a doctor with the requisite specialist knowledge in radiation protection. To this end, specialist medical associations provide recommendations based on up-to-date findings. Springer Medizin 2021-09-07 2021 /pmc/articles/PMC8422056/ /pubmed/34491367 http://dx.doi.org/10.1007/s00117-021-00898-0 Text en © The Author(s) 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Leitthema
Strahlenanwendung in der Diagnostik von COVID-19: Stellungnahme der Strahlenschutzkommission
title Strahlenanwendung in der Diagnostik von COVID-19: Stellungnahme der Strahlenschutzkommission
title_full Strahlenanwendung in der Diagnostik von COVID-19: Stellungnahme der Strahlenschutzkommission
title_fullStr Strahlenanwendung in der Diagnostik von COVID-19: Stellungnahme der Strahlenschutzkommission
title_full_unstemmed Strahlenanwendung in der Diagnostik von COVID-19: Stellungnahme der Strahlenschutzkommission
title_short Strahlenanwendung in der Diagnostik von COVID-19: Stellungnahme der Strahlenschutzkommission
title_sort strahlenanwendung in der diagnostik von covid-19: stellungnahme der strahlenschutzkommission
topic Leitthema
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422056/
https://www.ncbi.nlm.nih.gov/pubmed/34491367
http://dx.doi.org/10.1007/s00117-021-00898-0
work_keys_str_mv AT strahlenanwendunginderdiagnostikvoncovid19stellungnahmederstrahlenschutzkommission